Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
19 Sep 2016 EMA Recommends Granting a Marketing Authorisation for Palbociclib Breast cancer - Anticancer agents & Biologic therapy
16 Sep 2016 Start-Up of Human Cancer Models Initiative Translational research
15 Sep 2016 Niraparib Receives FDA Fast Track Designation for the Treatment of Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
08 Sep 2016 CDK4/6 Inhibitor LEE011 (Ribociclib) Receives FDA Breakthrough Therapy Designation Breast cancer - Anticancer agents & Biologic therapy
07 Sep 2016 Potential Risk of Hepatitis B Reactivation After Treatment With BCR-ABL Tyrosine Kinase Inhibitors Anticancer agents & Biologic therapy
06 Sep 2016 Press Release: ESMO Rewards Outstanding Oncologists
06 Sep 2016 Annals of Oncology Press Release: Deaths from Ovarian Cancer Decline Worldwide Due to Oral Contraceptive Use Gynaecologic malignancies
05 Sep 2016 Completion of Rolling Submission of New Drug Application for Brigatinib to the US FDA Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
31 Aug 2016 A New Report on Cancer Sites Linked to Overweight and Obesity Epidemiology/Etiology/Cancer Prevention
29 Aug 2016 Latest NICE Medtech Innovation Briefings and Technology Appraisal Guidance Recommendations for Cancer Breast cancer - Genitourinary cancers - Haematologic malignancies - Lung and other thoracic tumours - Gastrointestinal cancers
26 Aug 2016 Transparency in Drug Regulation Bioethics, legal and economic issues
24 Aug 2016 Adaptive Pathways: Key Learnings and Next Steps Bioethics, legal and economic issues
23 Aug 2016 Annals of Oncology Press Release: Expecting the Worst Increases Side-Effects in Breast Cancer Patients Receiving Adjuvant Hormone Therapy Breast cancer
22 Aug 2016 Evolving Field of CAR-T-Cell Therapy Haematologic malignancies - Cancer Immunology and Immunotherapy
19 Aug 2016 CAR T Cell Therapy for Diffuse Large B Cell Lymphoma Included in EMA’s PRIority MEdicines Scheme Haematologic malignancies - Cancer Immunology and Immunotherapy